SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-226471
Filing Date
2022-08-22
Accepted
2022-08-22 16:17:30
Documents
3
Period of Report
2022-10-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d378074ddef14a.htm DEF 14A 354090
2 GRAPHIC g378074g19z33.jpg GRAPHIC 188926
3 GRAPHIC g378074g25v76.jpg GRAPHIC 145281
  Complete submission text file 0001193125-22-226471.txt   815662
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-36830 | Film No.: 221183941
SIC: 2834 Pharmaceutical Preparations